Molecular methods for detecting and typing of Clostridium difficile

Pathology

Volumn 47, Issue 3, 2015, Pages 211-218

  Collins, Deirdre A ^a   Elliott, Briony ^a   Riley, Thomas V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Path West Laboratory Medicine WA   (Australia)

Author keywords

Clostridium difficile; diagnostics; molecular testing; PCR; ribotyping; sequencing; surveillance; typing

Indexed keywords

BACTERIUM IDENTIFICATION; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PSEUDOMEMBRANOUS COLITIS;

BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84930941085     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000238     Document Type: Article

References (114)

1. 1. Freeman, J., Bauer, M.P., Baines, S.D., et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23 (2010), 529–549.
2. 2. Bartlett, J.G., Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346 (2002), 334–339.
3. 3. Ackermann, G., Thomalla, S., Ackermann, F., et al. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea. J Med Microbiol 54 (2005), 149–153.
4. 4. Khanna, S., Pardi, D.S., Aronson, S.L., et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 107 (2012), 89–95.
5. 5. Slimings, C., Armstrong, P., Beckingham, W.D., et al. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012. Med J Aust 200 (2014), 272–276.
6. 6. Heinlen, L., Ballard, J.D., Clostridium difficile infection. Am J Med Sci 340 (2010), 247–252.
7. 7. Rupnik, M., Clostridium difficile toxinotyping. Methods Mol Biol 646 (2010), 67–76.
8. 8. Rupnik, M., Kato, N., Grabnar, M., et al. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 41 (2003), 1118–1125.
9. 9. Goorhuis, A., Bakker, D., Corver, J., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47 (2008), 1162–1170.
10. 10. Goorhuis, A., Debast, S.B., van Leengoed, L.A., et al. Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs. J Clin Microbiol, 46, 2008, 1157 (author reply 58).
11. 11. McDonald, L.C., Killgore, G.E., Thompson, A., et al. An epidemic, toxin genevariant strain of Clostridium difficile. N Engl J Med 353 (2005), 2433–2441.
12. 12. Bowman, R.A., Riley, T.V., Laboratory diagnosis of Clostridium difficile-associated diarrhoea. Eur J Clin Microbiol Infect Dis 7 (1988), 476–484.
13. 13. Wilkins, T.D., Lyerly, D.M., Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 41 (2003), 531–534.
14. 14. Lyerly, D.M., Barroso, L.A., Wilkins, T.D., Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol 29 (1991), 2639–2642.
15. 15. Planche, T.D., Davies, K.A., Coen, P.G., et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 13 (2013), 936–945.
16. 16. Brecher, S.M., Novak-Weekley, S.M., Nagy, E., Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 57 (2013), 1175–1181.
17. 17. Burnham, C.A., Carroll, K.C., Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26 (2013), 604–630.
18. 18. Kato, N., Ou, C.Y., Kato, H., et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 29 (1991), 33–37.
19. 19. Wren, B., Clayton, C., Tabaqchali, S., Rapid identification of toxigenic Clostridium difficile by polymerase chain reaction. Lancet, 335, 1990, 423.
20. 20. Gumerlock, P.H., Tang, Y.J., Weiss, J.B., et al. Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol 31 (1993), 507–511.
21. 21. MacCannell, D.R., Louie, T.J., Gregson, D.B., et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol 44 (2006), 2147–2152.
22. 22. Drudy, D., Kyne, L., O'Mahony, R., et al. GyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis 13 (2007), 504–505.
23. 23. Drudy, D., Harnedy, N., Fanning, S., et al. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 28 (2007), 932–940.
24. 24. Collins, D.A., Hawkey, P.M., Riley, T.V., Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control, 2, 2013, 21.
25. 25. Lim, S.K., Stuart, R.L., Mackin, K.E., et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis 58 (2014), 1723–1730.
26. 26. Kok, J., Wang, Q., Thomas, L.C., et al. Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution. J Clin Microbiol 49 (2011), 3719–3721.
27. 27. Androga, G., McGovern, A., Elliott, B., et al. Evaluation of the Cepheid Xpert(R) C. difficile/Epi and Meridian Bioscience illumigene(R) C. difficile for detecting Clostridium difficile ribotype 033 strains. J Clin Microbiol, 2014 DOI 10.1128/JCM.03297-14.
28. 28. Dubberke, E.R., Han, Z., Bobo, L., et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 49 (2011), 2887–2893.
29. 29. Cohen Stuart, H., Gerding Dale, N., Johnson, S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31 (2010), 431–455.
30. 30. Cheng, A.C., Ferguson, J.K., Richards, M.J., et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust 194 (2011), 353–358.
31. 31. McDonald, L.C., Coignard, B., Dubberke, E., et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28 (2007), 140–145.
32. 32. Gould, C.V., Edwards, J.R., Cohen, J., et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 57 (2013), 1304–1307.
33. 33. Goldenberg, S.D., Public reporting of Clostridium difficile and improvements in diagnostic tests. Infect Control Hosp Epidemiol 32 (2011), 1231–1232 (author reply 33).
34. 34. Tenover, F.C., Novak-Weekley, S., Woods, C.W., et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 48 (2010), 3719–3724.
35. 35. Goldenberg, S.D., Gumban, M., Hall, A., et al. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction. Diagn Microbiol Infect Dis 70 (2011), 417–419.
36. 36. Peterson, L.R., Robicsek, A., Does my patient have Clostridium difficile infection. Ann Intern Med 151 (2009), 176–179.
37. 37. Tenover, F.C., Baron, E.J., Peterson, L.R., et al. Laboratory diagnosis of Clostridium difficile infection: can molecular amplification methods move us out of uncertainty. J Mol Diagn 13 (2011), 573–582.
38. 38. Larson, A.M., Fung, A.M., Fang, F.C., Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol 48 (2010), 124–130.
39. 39. Babady, N.E., Stiles, J., Ruggiero, P., et al. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 48 (2010), 4519–4524.
40. 40. Crobach, M.J., Dekkers, O.M., Wilcox, M.H., et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15 (2009), 1053–1066.
41. 41. Wilcox, M.H., Planche, T., Fang, F.C., et al. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection. J Clin Microbiol 48 (2010), 4347–4353.
42. 42. Baker, I., Leeming, J.P., Reynolds, R., et al. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection. J Hosp Infect 84 (2013), 311–315.
43. 43. Polage, C.R., Chin, D.L., Leslie, J.L., et al. Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis 74 (2012), 369–373.
44. 44. Longtin, Y., Trottier, S., Brochu, G., et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 56 (2013), 67–73.
45. 45. Miller, J.R., Barrett, L.J., Kotloff, K., et al. A rapid test for infectious and inflammatory enteritis. Arch Intern Med 154 (1994), 2660–2664.
46. 46. Steiner, T.S., Flores, C.A., Pizarro, T.T., et al. Fecal lactoferrin, interleukin-1 beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 4 (1997), 719–722.
47. 47. Pawlowski, S.W., Archbald-Pannone, L., Carman, R.J., et al. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile. J Hosp Infect 73 (2009), 185–187.
48. 48. Shastri, Y.M., Bergis, D., Povse, N., et al. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med 121 (2008), 1099–1106.
49. 49. LaSala, P.R., Ekhmimi, T., Hill, A.K., et al. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens. J Clin Microbiol 51 (2013), 311–313.
50. 50. Poxton, I.R., Byrne, M.D., Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species. J Gen Microbiol 122 (1981), 41–46.
51. 51. Mahony, D.E., Clow, J., Atkinson, L., et al. Development and application of a multiple typing system for Clostridium difficile. Appl Environ Microbiol 57 (1991), 1873–1879.
52. 52. Sell, T.L., Schaberg, D.R., Fekety, F.R., Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J Clin Microbiol 17 (1983), 1148–1152.
53. 53. Cartmill, T.D., Orr, K., Freeman, R., et al. Nosocomial infection with Clostridium difficile investigated by pyrolysis mass spectrometry. J Med Microbiol 37 (1992), 352–356.
54. 54. Ogunsola, F.T., Ryley, H.C., Duerden, B.I., Sodium dodecyl sulfate-polyacry-lamide gel electrophoresis analysis of EDTA-extracted cell-surface protein antigens is a simple and reproducible method for typing Clostridium difficile. Clin Infect Dis 20:Suppl 2 (1995), S327–S330.
55. 55. Delmée, M., Homel, M., Wauters, G., Serogrouping of Clostridium difficile strains by slide agglutination. J Clin Microbiol 21 (1985), 323–327.
56. 56. Mulligan, M.E., Peterson, L.R., Kwok, R.Y., et al. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 26 (1988), 41–46.
57. 57. Brazier, J.S., Typing of Clostridium difficile. Clin Microbiol Infect 7 (2001), 428–431.
58. 58. Kuijper, E.J., van den Berg, R.J., Brazier, J.S., Comparison of molecular typing methods applied to Clostridium difficile. Methods Mol Biol 551 (2009), 159–171.
59. 59. Barbut, F., Mario, N., Frottier, J., et al. Use of the arbitrary primer polymerase chain reaction for investigating an outbreak of Clostridium difficile-associated diarrhea in AIDS patients. Eur J Clin Microbiol Infect Dis 12 (1993), 794–795.
60. 60. Church, D.L., Chow, B.L., Lloyd, T., et al. Evaluation of automated repetitive-sequence-based PCR (DiversiLab) compared to PCR ribotyping for rapid molecular typing of community- and nosocomial-acquired Clostridium difficile. Diagn Microbiol Infect Dis 70 (2011), 183–190.
61. 61. Klaassen, C.H., van Haren, H.A., Horrevorts, A.M., Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism. J Clin Microbiol 40 (2002), 101–104.
62. 62. Rupnik, M., Avesani, V., Janc, M., et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36 (1998), 2240–2247.
63. 63. Eidhin, D.N., Ryan, A.W., Doyle, R.M., et al. Sequence and phylogenetic analysis of the gene for surface layer protein, slpA, from 14 PCR ribotypes of Clostridium difficile. J Med Microbiol 55 (2006), 69–83.
64. 64. Tasteyre, A., Karjalainen, T., Avesani, V., et al. Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol 38 (2000), 3179–3186.
65. 65. Alonso, R., Martin, A., Pelaez, T., et al. An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile. J Med Microbiol 54 (2005), 155–157.
66. 66. Belmares, J., Johnson, S., Parada, J.P., et al. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. Clin Infect Dis 49 (2009), 1141–1147.
67. 67. Tenover, F.C., Akerlund, T., Gerding, D.N., et al. Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol 49 (2011), 1831–1837.
68. 68. Bowman, R.A., O'Neill, G.L., Riley, T.V., Non-radioactive restriction fragment length polymorphism (RFLP) typing of Clostridium difficile. FEMS Microbiol Lett 63 (1991), 269–272.
69. 69. Gurtler, V., Typing of Clostridium difficile strains by PCR-amplification of variable length 16S-23S rDNA spacer regions. J Gen Microbiol 139 (1993), 3089–3097.
70. 70. O'Neill, G.L., Ogunsola, F.T., Brazier, J.S., et al. Modification of a PCR ribotyping method for application as a routine typing scheme for Clos-tridium difficile. Anaerobe 2 (1996), 205–209.
71. 71. Stubbs, S.L.J., Brazier, J.S., O'Neill, G.L., et al. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37 (1999), 461–463.
72. 72. Bidet, P., Barbut, F., Lalande, V., et al. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 175 (1999), 261–266.
73. 73. Indra, A., Huhulescu, S., Schneeweis, M., et al. Characterization of Clos-tridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol 57 (2008), 1377–1382.
74. 74. Marsh, J.W., O'Leary, M.M., Shutt, K.A., et al. Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in hospitals. J Clin Microbiol 44 (2006), 2558–2566.
75. 75. Fawley, W.N., Wilcox, M.H., An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype. J Clin Microbiol 49 (2011), 4333–4337.
76. 76. Manzoor, S.E., Tanner, H.E., Marriott, C.L., et al. Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission. J Clin Microbiol 49 (2011), 3523–3530.
77. 77. van den Berg, R.J., Schaap, I., Templeton, K.E., et al. Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol 45 (2007), 1024–1028.
78. 78. Lemee, L., Dhalluin, A., Pestel-Caron, M., et al. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol 42 (2004), 2609–2617.
79. 79. Griffiths, D., Fawley, W., Kachrimanidou, M., et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 48 (2010), 770–778.
80. 80. Eyre, D.W., Cule, M.L., Wilson, D.J., et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369 (2013), 1195–1205.
81. 81. Eyre, D.W., Fawley, W.N., Best, E.L., et al. Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol 51 (2013), 4141–4149.
82. 82. Dalpke, A.H., Hofko, M., Zorn, M., et al. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens. J Clin Microbiol 51 (2013), 1906–1908.
83. 83. Le Guern, R., Herwegh, S., Grandbastien, B., et al. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples. J Clin Microbiol 50 (2012), 3089–3090.
84. 84. Leitner, E., Einetter, M., Grisold, A.J., et al. Evaluation of the BD MAX Cdiff assay for the detection of the toxin B gene of Clostridium difficile out of faecal specimens. Diagn Microbiol Infect Dis 76 (2013), 390–391.
85. 85. Putsathit, P., Morgan, J., Bradford, D., et al. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens. Pathology 47 (2015), 165–168.
86. 86. Beck, E.T., Buchan, B.W., Riebe, K.M., et al. Multicenter evaluation of the Quidel Lyra Direct C. difficile nucleic acid amplification assay. J Clin Microbiol 52 (2014), 1998–2002.
87. 87. Deak, E., Miller, S.A., Humphries, R.M., Comparison of illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection. J Clin Microbiol 52 (2014), 960–963.
88. 88. Gilbreath, J.J., Verma, P., Abbott, A.N., et al. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile. Diagn Microbiol Infect Dis 80 (2014), 13–18.
89. 89. Tojo, M., Nagamatsu, M., Hayakawa, K., et al. Evaluation of an automated rapid diagnostic test for detection of Clostridium difficile. PLoS One, 9, 2014, e106102.
90. 90. Carroll, K.C., Buchan, B.W., Tan, S., et al. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay. J Clin Microbiol 51 (2013), 4120–4125.
91. 91. Denys, G.A., Portrait Toxigenic Clostridium difficile assay, an isothermal amplification assay detects toxigenic C. difficile in clinical stool specimens. Exp Rev Mol Diagn 14 (2014), 17–26.
92. 92. Buchan, B.W., Mackey, T.L., Daly, J.A., et al. Multicenter clinical evaluation of the Portrait Toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J Clin Microbiol 50 (2012), 3932–3936.
93. 93. Hong, G., Park, K.S., Ki, C.S., et al. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples. Diagn Microbiol Infect Dis 80 (2014), 177–180.
94. 94. Hart, J., Putsathit, P., Knight, D.R., et al. Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies. Eur J Clin Microbiol Infect Dis 33 (2014), 1555–1564.
95. 95. Soh, Y.S., Yang, J.J., You, E., et al. Comparison of two molecular methods for detecting toxigenic. Clostridium difficile. Ann Clin Lab Sci 44 (2014), 27–31.
96. 96. McElgunn, C.J., Pereira, C.R., Parham, N.J., et al. A low complexity rapid molecular method for detection of Clostridium difficile in stool. PLoS One, 9, 2014, e83808.
97. 97. Noren, T., Unemo, M., Magnusson, C., et al. Evaluation of the rapid loop-mediated isothermal amplification assay illumigene for diagnosis of Clostridium difficile in an outbreak situation. APMIS 122 (2014), 155–160.
98. 98. Couturier, B., Schlaberg, R., Konzak, C., et al. TcdA as a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile. J Clin Lab Anal 27 (2013), 171–176.
99. 99. Walkty, A., Lagace-Wiens, P.R., Manickam, K., et al. Evaluation of an algorithmic approach in comparison with the illumigene assay for laboratory diagnosis of Clostridium difficile infection. J Clin Microbiol 51 (2013), 1152–1157.
100. 100. Bamber, A.I., Fitzsimmons, K., Cunniffe, J.G., et al. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification. Br J Biomed Sci 69 (2012), 112–118.
101. 101. Bruins, M.J., Verbeek, E., Wallinga, J.A., et al. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 31 (2012), 3035–3039.
102. 102. Viala, C., Le Monnier, A., Maataoui, N., et al. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile. J Microbiol Methods 90 (2012), 83–85.
103. 103. Pancholi, P., Kelly, C., Raczkowski, M., et al. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and illumigene C. difficile assays. J Clin Microbiol 50 (2012), 1331–1335.
104. 104. Boyanton, B.L. Jr., Sural, P., Loomis, C.R., et al. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic. Clostridium difficile detection. J Clin Microbiol 50 (2012), 640–645.
105. 105. Lalande, V., Barrault, L., Wadel, S., et al. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 49 (2011), 2714–2716.
106. 106. Shin, S., Kim, M., Kim, M., et al. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med 32 (2012), 355–358.
107. 107. Chapin, K.C., Dickenson, R.A., Wu, F., et al. Comparison of five assays for detection of Clostridium difficile toxin. J Mol Diagn 13 (2011), 395–400.
108. 108. Zidaric, V., Kevorkijan, B.K., Oresic, N., et al. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory. J Med Microbiol 60 (2011), 1131–1136.
109. 109. Selvaraju, S.B., Gripka, M., Estes, K., et al. Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays. Diagn Microbiol Infect Dis 71 (2011), 224–229.
110. 110. Knetsch, C.W., Bakker, D., de Boer, R.F., et al. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection. J Clin Microbiol 49 (2011), 227–231.
111. 111. Terhes, G., Urban, E., Soki, J., et al. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J Clin Microbiol 47 (2009), 3478–3481.
112. 112. Stamper, P.D., Alcabasa, R., Aird, D., et al. Comparison of a commercial realtime PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 47 (2009), 373–378.
113. TM gastrointestinal panel for the etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 53 (2015), 915–925.
114. 114. Stockmann, C., Rogatcheva, M., Harrel, B., et al. How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection. Clin Microbiol Infect 21 (2015), 179.e9–179.e15.